The maker of the EpiPen has raised the price of two injectable treatments to about $600, six times the price nine years ago. Why do drug companies do this? Because they can.
Live Science newsletter
Stay up to date on the latest science news by signing up for our Essentials newsletter.
Thank you for signing up to Live Science. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.